The CCF Advisory Boards consist of key opinion leaders, scientists, clinicians and healthcare providers who are active in the education, treatment, clinical and basic research of cholangiocarcinoma and are committed to furthering the CCF mission. Advisory Board members serve to guide the CCF with a diversity of perspectives, providing assistance and insight into the vision and mission of the CCF from a medical/scientific perspective. In addition, the Advisory Boards provide guidance on strategic medical and scientific direction for the Executive Board of Directors.
Scientific & Medical Advisory Board
Co-Chair, Kate (Katie) Kelley, MD
Co-Chair, Nabeel Bardeesy, PhD
Harvard Medical School, Massachusetts General Hospital